Mason Street Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-311,727
| Closed | -$19.3M | – | 175 |
|
|
2020
Q4 | $19.3M | Sell |
311,727
-4,843
| -2% | -$298K | 0.33% | 51 |
|
|
2020
Q3 | $19.1M | Sell |
316,570
-6,461
| -2% | -$389K | 0.37% | 47 |
|
|
2020
Q2 | $19M | Sell |
323,031
-11,430
| -3% | -$684K | 0.38% | 47 |
|
|
2020
Q1 | $18.6M | Hold |
334,461
| – | – | 0.43% | 40 |
|
|
2019
Q4 | $21.5M | Buy |
334,461
+101,417
| +44% | +$5.81M | 0.41% | 39 |
|
|
2019
Q3 | $11.8M | Sell |
233,044
-239
| -0.1% | -$11.2K | 0.24% | 72 |
|
|
2019
Q2 | $10.6M | Buy |
233,283
+360
| +0.2% | +$16.8K | 0.22% | 78 |
|
|
2019
Q1 | $11.1M | Buy |
232,923
+2,807
| +1% | +$140K | 0.23% | 80 |
|
|
2018
Q4 | $12M | Buy |
230,116
+709
| +0.3% | +$38.1K | 0.29% | 64 |
|
|
2018
Q3 | $14.2M | Buy |
229,407
+77
| +0% | +$4.57K | 0.29% | 63 |
|
|
2018
Q2 | $12.7M | Buy |
229,330
+1,915
| +0.8% | +$103K | 0.28% | 65 |
|
|
2018
Q1 | $14.4M | Sell |
227,415
-564
| -0.2% | -$36.3K | 0.33% | 53 |
|
|
2017
Q4 | $14M | Buy |
227,979
+327
| +0.1% | +$20.5K | 0.31% | 55 |
|
|
2017
Q3 | $14.5M | Sell |
227,652
-994
| -0.4% | -$58K | 0.35% | 53 |
|
|
2017
Q2 | $12.7M | Sell |
228,646
-2,511
| -1% | -$137K | 0.32% | 51 |
|
|
2017
Q1 | $12.6M | Buy |
231,157
+2,541
| +1% | +$139K | 0.32% | 50 |
|
|
2016
Q4 | $13.4M | Buy |
228,616
+2,583
| +1% | +$141K | 0.36% | 45 |
|
|
2016
Q3 | $12.2M | Buy |
226,033
+1,187
| +0.5% | +$76.2K | 0.35% | 51 |
|
|
2016
Q2 | $16.5M | Buy |
224,846
+2,472
| +1% | +$175K | 0.48% | 38 |
|
|
2016
Q1 | $14.2M | Buy |
222,374
+4,430
| +2% | +$279K | 0.43% | 41 |
|
|
2015
Q4 | $15M | Buy |
217,944
+2,193
| +1% | +$145K | 0.47% | 36 |
|
|
2015
Q3 | $12.8M | Buy |
215,751
+1,104
| +0.5% | +$70K | 0.43% | 40 |
|
|
2015
Q2 | $14.3M | Buy |
214,647
+592
| +0.3% | +$39K | 0.44% | 42 |
|
|
2015
Q1 | $13.8M | Sell |
214,055
-363,959
| -63% | -$22.8M | 0.42% | 44 |
|
|
2014
Q4 | $34.1M | Buy |
578,014
+4,552
| +0.8% | +$257K | 0.24% | 89 |
|
|
2014
Q3 | $29.4M | Sell |
573,462
-110,510
| -16% | -$5.52M | 0.23% | 93 |
|
|
2014
Q2 | $33.3M | Buy |
683,972
+5,785
| +0.9% | +$285K | 0.26% | 71 |
|
|
2014
Q1 | $35.2M | Buy |
678,187
+21,800
| +3% | +$1.16M | 0.29% | 58 |
|
|
2013
Q4 | $34.9M | Buy |
656,387
+95,971
| +17% | +$4.89M | 0.28% | 62 |
|
|
2013
Q3 | $25.9M | Buy |
560,416
+214,053
| +62% | +$9.4M | 0.29% | 71 |
|
|
2013
Q2 | $15.5M | Buy |
+346,363
| New | +$15M | 0.17% | 163 |
|
Other funds holding BMY
Mason Street Advisors's BMY Position: Q1 2021 in Review
Mason Street Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 311,727 shares — an estimated $19.3M sold.
Mason Street Advisors first reported a position in BMY in Q2 2013 and held it in 31 quarters. The position peaked at $35.2M in Q1 2014. 2,369 funds tracked by Wall St. Rank hold BMY as of Q1 2021.
- Mason Street Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 311,727 Bristol-Myers Squibb shares in Q1 2021, an estimated $19.3M.
- Mason Street Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Bristol-Myers Squibb position peaked at $35.2M in Q1 2014.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.